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BACKGROUND:  Serum  neopterin  concentrations  rise
during activation  of the cellular immune system. It
is  suggested  that  neopterin  interacts  with  cellular
redox  mechanisms.  This  induces  oxidative  stress,
which inhibits intracellular Ca2+ transients in various
cell  types.  In  type  II  alveolar  epithelial  cells,  Ca2+
increase is considered involved in the exocytosis of
surfactants.  This  exocytosis  is  disturbed  during
inflammation.
Aims: To clarify whether neopterin affects adenosine
triphosphate  (ATP)-induced  Ca2+ transients  in  an
alveolar epithelial cell line (L2).
Methods:  Ca2+ transients  were  detected  as  fura-2
fluorescence by an image analysis system.
Results: Cells were exposed for 100sec to ATP (1m M,
repeated  four  times).  The  first  application  of  ATP
induced  an  increase  of  the  fluorescence  ratio  by
approximately  100%,  while  the  following  stimula-
tions resulted in smaller transients. In a second set of
experiments, L2 cells were exposed to ATP or ATP +
neopterin (100nM), alternately. Simultaneous appli-
cation of neopterin inhibited Ca2+ transients almost
completely.
Conclusions: Inhibition of Ca2+ transients by neop-
terin may lead to suppressed exocytosis of surfactant
proteins in alveolar epithelial cells. This might con-
tribute to the deterioration of pulmonary functions in
the course of inflammatory processes.
Key  words:  Neopterin,  Calcium,  Alveolar  epithelium,
Inflammation
Introduction
Neopterin is a pyrazino pyrimidine compound that is
biosynthesized from  guanosine  triphosphate in  the
pathway leading to tetrahydrobiopterin. Due to a low
constitutive activity of the second enzyme within this
pathway,  6-pyrovoyl  tetrahydropterin  synthase,
human monocytes/macrophages produce and release
large amounts of neopterin following activation with
T-lymphocyte-derived interferon-g. Thus,  serum  and
urinary  neopterin  levels  serve  as  an  indicator  in
patients with diseases associated with an increased
activity of the cellular immune system (e.g. viral and
bacterial  infections,  acute  graft  rejections,  and
acquired immune deficiency syndrome). In the lung,
correlations between serum levels of neopterin and
the severity of  disease have been demonstrated for
inflammatory  disorders  such  as  sarcoidosis,  lung
cancer, tuberculosis, and sepsis.1 Apart from being a
clinical marker for these conditions, neopterin seems
to  exhibit  distinct  biochemical  functions  via  inter-
actions  with  cellular  redox  mechanisms  and  the
promotion of  oxidative stress. Therefore, neopterin
may play a role as a modulator during host defence
reactions. Neopterin was  shown  to  enhance chlor-
amine-T-mediated and H2O2-mediated chemilumines-
cence as well as toxicity against bacteria,2 to activate
the  transcripiton  factor  NF-kB  with  a  subsequent
stimulation  of  inducible  nitric oxide  synthase gene
expression  in  vascular  smooth  muscle  cells,3 or  to
induce apoptosis in different cell lines.4 Since these
events  are  mediated  by  oxidative  stress,  one  may
speculate that neopterin enhances oxidative mecha-
nisms, either by stressing pro-oxidative mediators or
by  the  consumption  of  anti-oxidative  counter-reg-
ulatory means, or both.
Surfactant proteins are stored in and released from
intracellular lamellar bodies by alveolar type II epithe-
lial  cells.  The  importance  of  an  increase  of  cyto-
plasmic  Ca2+ ([Ca2+]i)  for  surfactant  release is sup-
ported by studies using Ca2+ ionophores and by the
observation  that  surfactant  release  by  b-adrenergic
and  purinergic  stimulation  is  accompanied  by  an
elevation in intracellular Ca2+.5,6 It has been demon-
strated that oxidative stress inhibits intracellular Ca2+
transients in various cell types; for example, in retinal
cells7or in ventricular cardiomyocytes.8However, the
influence  of oxidative stress on [Ca2+]i has not yet
been  investigated  in  lung  epithelial  cells.  Distur-
bances  of  cellular  Ca2+ homeostasis  by  oxidative
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surfactant  release  and  may  thereby  contribute  to
pulmonary dysfunctions commonly observed in the
course of inflammatory diseases.
In the present study, we investigate the effects of
neopterin on adenosine triphosphate (ATP)-induced
Ca2+ transients in a type II-like alveolar epithelial cell
line  (L2). Within  type  II-like  cells, ATP  is  a  potent
stimulus  of  [Ca2+]i due  to  intracellular  Ca2+
release.9,10 Neopterin,  the  hypothetical  inducer  of
oxidative stress, was added to look for its inhibitory
potential on ATP-induced Ca2+ transients.
Materials and methods
Culture of L2 cells
The lung epithelial cell line, L2 (adult female Lewis
strain  rat),  was purchased from  the American Type
Culture  Collection,  No.  CCL-149  (Rockville,  MD,
USA). Cells were grown in 25cm2 culture  flasks in
Dulbecco’s  modified  Eagle’s  medium  (DMEM)  con-
taining 5% fetal calf serum (FCS), L-glutamine (2 mM),
and  penicillin–streptomycin  (100U/ml–100mg/ml).
Every 5th day, confluent cultures were passaged by
incubation  (10min  at  37°C)  in  phosphate-buffered
saline solution containing  0.05%  trypsin and 0.02%
ethylenediamine tetraacetic acid (EDTA). For experi-
ments, cells were seeded (104 cells/cm2) into 24-well
plates  (diameter,  35mm/dish;  media  volume,  1ml)
containing  coverslips  for  fluorescence  microscopy
and  were grown  to confluence.  Passages 45–55  of
subcultured  cells  were  used  for  the  present
experiments.
Fura-2 experiments
L2 cells were incubated with 4mM Fura-2 for 15min
and  were  mounted  in  a  perfusion  chamber  that
allowed complete changing of the external medium
within 1min, and they were investigated at 37°C in
permanent perfusion. Fura-2 fluorescence was recor-
ded  using  a  Zeiss  IM  35  microscope  with  a  Zeiss
Ultrafluor 100 objective (Carl Zeiss, Jena, Germany).
The  excitation pathway consisted of a  Leitz  xenon
lamp (150W) and a filter wheel with two excitation
filters  (340nm,  380nm,  10nm  bandwidth).  The
emitted light was passed through a filter combination
(Zeiss  LP  429  plus  Schott  BG39). TV  images  were
acquired by an intensified video camera, C 2400–77H,
with  an  amplifier  unit,  C  2400–80  (Hamamatsu
Photonics, Hamamatsu City, Japan) and passed to a
Hamamatsu Interactive Calcium Monitoring System.
Two subsequent TV images were recorded at 340nm
excitation and averaged online. The resulting image
was stored in a personal computer. Then the filter was
changed  to  380nm  within  40msec  and  the  same
procedure  as  described  for  340nm  excitation  was
repeated. The next image pair was taken after 10sec.
Parameters  for  image  acquisition  were  256  ´ 256
pixels/image with 256 gray levels, and each digitized
image  was  corrected for  the  camera  dark  current.
Images of cells were discriminated at their borders
from the extracellular space by transforming all gray
values below a threshold value to zero. In a second
step, the gray-value distribution of one selected ratio
image  was  exhibited  as  a  histogram  to  chose  the
borders for an interactive gray-value scaling. All ratio
images were calculated pixel by pixel according to
the  chosen  gray-value  scaling  and  documented  in
pseudocolor mode.
Neopterin excited with UV light acts as a fluores-
cent  dye  (excitation  maximum,  353nm;  emission,
438nm).  To  prevent  overlap  between  Fura-2  and
neopterin fluorescence emission, the neopterin con-
centration  was  kept  below  the  level  of  detectable
fluorescence.
Experimental set-up
As shown in Figure 1, each experiment started with a
pre-run phase by perfusing the cells for 5min with
standard  Tyrode’s  solution  (composed  of  NaCl,
135 mM; KCl, 4 mM; CaCl2, 1.8 mM; MgCl2, 1 mM;
glucose, 11 mM; and Hepes, 2 mM; adjusted to pH
7.2 with NaOH). In control experiments, cells were
exposed  at  regular  intervals  (every  250sec,  for
100sec) to Tyrode’s solution containing ATP (1mM,
repeated four times). Between the ATP incubations,
cells  were  perfused  with Tyrode’s  solution.  In  test
experiments, the L2 cells were superfused alternately
with Tyrode’s solution containing ATP (1mM) or with
Tyrode’s  solution  containing  a  combination  of ATP
(1mM) with neopterin (100nM).
Reagents
DMEM  with  and  without  phenol  red,  FCS,
L-glutamine,  penicillin–streptomycin,  and  trypsin–
EDTA  was  purchased  from  Gibco  Life Technology
(Eggenstein,  Germany).  Neopterin  was  purchased
from  Schircks  Lab.  (Jona,  Switzerland).  All  other
chemicals were from Sigma Chemicals (Deisenhofen,
Germany).
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FIG.  1.  Schedule  for  the  first  and  second  experimental
protocols (I, incubation; Neo, neopterin).Statistical analysis
For further analyses, those cells that exhibited suffi-
cient fluorescence at the end of the experiment were
selected. On each of these cells, an average ratio value
was  calculated  in  a  representative  part.  This  was
plotted as a function of time. For standardization, the
first 10 ratio values were averaged and set to 100%. All
ratio  values  were  brought  into  relation  with  this
reference value. By this procedure, ratio changes are
transferred to percent changes. Thus, under control
conditions, each cell starts with values near 100%. At
each time point, the percent values of all cells were
averaged  and  their  standard  deviations  (SD)  were
calculated. Significance of differences was calculated
by analysis of variance followed by Tukey’s post test.
p < 0.05 was considered significant.
Results
L2 cells stimulated with 1mM of ATP develop [Ca2+]i
transients (i.e. [Ca2+]i increases and returns to control
levels in the presence of ATP after about 3min) (Fig.
2a), as indicated by the change in color. During the
washout phase in Tyrode’s solution, [Ca2+]i returned
to baseline values. This procedure was repeated three
times with ATP causing a rise in [Ca2+]i each time;
however, with a decreasing amplitude. This incuba-
tion protocol has been applied to a total of approx-
imately 200 different cells in nine independent runs.
Figure  2b  shows  a  representative  result  of  the
corresponding incubations according to the second
experimental protocol where cells were exposed to
either  ATP  or  ATP  with  neopterin  alternately.  In
comparison  with  the  first  protocol,  there  was  a
pronounced increase in [Ca2+]i after the first stimula-
tion with ATP. The second ATP pulse was performed in
the  presence  of  neopterin  (100nM).  This  time,  a
change in fluorescence ratio could not be detected,
indicating a stable [Ca2+]i. However, after a washout
phase, cells reacted again to stimulation with ATP. As
a  repetition  of  the  second  incubation,  the  fourth
incubation  was  performed  with  ATP  (1mM)  and
neopterin (100nM). Again, [Ca2+]i did not respond to
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FIG. 2. Pseudocolor images of the Ca
2+ distribution in L2 cells at different stages of experiments. (a) The upper row of images
was taken during an experiment with two consecutive ATP stimulations. In Tyrode’s solution, [Ca
2+]i in the cells is low (t =
00:05:00). After a stimulation with ATP, [Ca
2+]i rises in nearly all cells (t = 00:06:00). During the washout, [Ca
2+]i returns to
baseline level (t = 00:09:10). A second stimulation with ATP elicits an increase in [Ca
2+]i again (t = 00:10:10). (b) In the lower
row of images, an experiment is  exhibited during which the cells were stimulated with ATP or with ATP and neopterin,
alternately. After the expected increase in [Ca
2+]i following a stimulation with ATP (t = 00:06:00), the simultaneous application
of ATP and neopterin did not induce a change in [Ca
2+]i (t = 00:10:10).the  stimulation.  Similar  to  the  first  experimental
protocol (Fig. 2a), a total of nine different cell layers
with  approximately  200  individual  cells  were
investigated.
Figure  3  summarizes  the  results  of  the  statistical
analyses  performed  with the  digitized  fluorescence
ratio images. Figure 3a shows the changes in relative
fluorescence ratio as observed in L2 cells subjected to
the first experimental protocol. All four applications
of ATP led to a significant  increase in  fluorescence
ratio, and thus a rise in [Ca2+]i. In Fig. 3b, the results
of  the  second  experimental  protocol  are  demon-
strated. Again,  the  addition  of ATP  resulted  in  an
increased [Ca2+]i. There is no detectable change of
fluorescence ratio when cells were exposed to the
combination of ATP and neopterin for the first time.
This was not due to an inability of the cells to increase
[Ca2+]i because  a  consecutive  application  of  ATP
alone led to an increase in fluorescence ratio again.
The maximal changes in relative fluorescence ratio
of the first incubation procedure were compared with
the corresponding data from the second experimental
protocol (Fig. 3c). Both ATP-induced Ca2+ transients
observed in the first incubation procedure (first step,
214  ±  57%;  third  step,  127  ±  20%)  did  not  differ
significantly from the respective ratios of the second
set-up (first step, 181 ± 45%; third step, 140 ± 24%).
However, addition of neopterin to ATP inhibited the
intracellular Ca2+ transients significantly (in the sec-
ond step, from 139 ± 23% to 105 ± 11%, p < 0.001; in
the fourth step, from 124 ± 20% to 107 ± 10%, p <
0.001).
Discussion
In  summary,  the  present  study  demonstrates  that
neopterin inhibits ATP-induced Ca2+ transients in the
type  II-like  alveolar epithelial  cell  line  L2. ATP  has
been shown to be a potent stimulus  for  surfactant
release in type II cells.11A role of Ca2+in the secretion
of  surfactant  proteins  was suggested by  the use  of
Ca2+ ionophores.5 Considering  the  fact  that  ATP
evoked a high Ca2+ release in many studies,9,10 one
may  speculate  that [Ca2+]i is  a  supportive  step for
ATP-induced surfactant release. Among the potential
mechanisms  mediating  the  effects  of ATP  on  intra-
cellular  Ca2+ is  the  activation  of  L-type  voltage-
dependent Ca2+ channels, as reported for L2 cells by
Dietl et al.6 In addition, Ca2+ oscillations in primary
cultures of airway epithelial cells promoted by ATP
have  been  demonstrated  to  be  due  to  P2U
purinoceptor  stimulation  and  to  the  continuous
production of inositol-1,4,5-triphosphate (IP3).12The
inhibitory  capacity  of  oxidative  stress  on  the  ion
permeability  of  voltage-sensitive  Ca2+ channels  has
been  demonstrated.7,8 In  various  other  cell  lines,
oxidative  stress  suppressed  the  activation  of  IP3
induced by both hormonal and non-hormonal stim-
uli.12,13 Concerning L2 cells, exogenous nitric oxide
donors, which represent another source of reactive
oxygen  species (ROS),  have been shown to inhibit
spontaneous  depolarizations  by  L-type  Ca2+ cur-
rents.14 It  has  been  proposed  that  pteridine
compounds  act  by  the  modulation  of  oxygen
G. Hoffmann et al.
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FIG. 3. Averaged time courses of relative change of [Ca
2+]i.
(a) Each of four consecutive applications of ATP induces an
increase in [Ca
2+]i. Data are presented as mean ± SD of cells.
(b) Application of ATP induces an increase in [Ca
2+]i, whereas
simultaneous application of ATP and neopterin (NEO) fails to
change [Ca
2+]i. Data are presented as mean ± SD of 200 cells.
(c) Comparison of maximal changes in fluorescence ratio for
both  the  first  (open  bars)  and  the  second  (hatched  bars)
experimental  protocols.  1st,  ATP  versus  ATP;  2nd,  ATP
versus ATP + neopterin (N); 3rd, ATP versus ATP; 4th, ATP
versus ATP + neopterin. * Significant differences.radical-mediated  processes  (e.g.  by  activating  the
ROS-sensitive transcription factor NF-kB).3The activa-
tion of NF-kB could be prevented by application of
anti-oxidants. This may provide an explanation for the
stimulatory effects of neopterin on gene expression of
inducible  nitric  oxide  synthase  or  tumor  necrosis
factor-a.3,15 Taken  together,  these  data  imply  that
neopterin  may  not  only  affect  Ca2+ transients  in
alveolar epithelial cells via short-term mediated oxida-
tive  stress.  Furthermore,  long-term  interactions
between  neopterin  and  various  other  mediators of
the  inflammatory  system  (e.g.  activation  of  nitric
oxide synthases with the subsequent production of
nitric oxide) may result in prolonged suppression of
Ca2+-dependent processes.
According to our knowledge, only one investigation
has been performed to date dealing with the effects of
neopterin on intracellular Ca2+.16 Most interestingly,
the  data  of  W¨ oll  et  al. are  contradictory  to  our
observations, since they found an increase in [Ca2+]iin
the  human  myelomonocytic  cell  line THP-1  in  the
presence  of  neopterin.  These  results  suggest  that
neopterin interferes with [Ca2+]i in a cell type-specific
manner. In the case of monocytes, Ca2+increases have
been shown to play an important role in the activation
of these cells, with the stimulation of NADPH oxidase
being, at least in part, dependent on an elevation of
[Ca2+]i.17 It is tempting to speculate that neopterin-
induced Ca2+transients in immune cells contributes to
the process of respiratory burst, while in non-immune
cells  (e.g.  alveolar epithelium)  neopterin  exerts  an
inhibitory effect on intracellular Ca2+.
Considering  inflammatory  disorders  within  the
pulmonary  system  (e.g.  sarcoidosis,  lung  cancer,
tuberculosis,  adult  respiratory  distress  syndrome,
ARDS),  the severity  as well  as  the outcome of  the
disease was found to be correlated with an increase in
serum  neopterin levels  up to ~ 150nM.1 Thus, the
neopterin  concentration of  100nM  applied  in  this
study is representative for inflammatory diseases of
the  lung.  A  decreased  production  and  release  of
surfactant  proteins  is  observed  frequently  in  these
situations. By inhibition of Ca2+ transients in type II
alveolar epithelial cells, neopterin may contribute to
this  detrimental  process,  thereby  representing  an
important mediator of the damage and dysfunction of
the airway epithelium during lung inflammation.
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